News Headlines Article

Public gets mixed messages regarding efficacy of Avastin for treating breast cancer
Public Radio International

On Friday, the FDA ruled that cancer drug Avastin should not be used to treat breast cancer because Avastin’s risky side-effects outweigh its benefits for breast cancer patients.

“Women who take Avastin for metastatic breast cancer risk potentially life threatening or serious side-effects, such as heart attacks or heart failure, severe high blood pressure, bleeding or hemorrhaging,” FDA Commissioner Dr. Margaret Hamburg said.